Scholars Central

Conference abstract

CRISPR logic circuits for next generation CRISPR-based gene therapies

Authors: Samira Kiani

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Cas9 is an RNA guided DNA endonuclease of the bacterial Clustered Regularly Interspaced Short Palindromic Repeat (CRISPR) system that has been adopted for programmable genome editing and transcriptional regulation. As the complexity of genetic interrogations with this technology is rapidly growing, there will soon be a need for safer and more specific CRISPR-based therapies. To this end, we apply the design principles of synthetic biology to develop genetic logic gates, layered genetic circuits and kill switches, which allow us to exert internal control over the function of the CRISPR system. We develop RNA Pol II driven gRNAs that enable cell and context specific expression of them. This strategy combined with synthetic promoter engineering allow us to develop genetic circuits to have more specific CRISPRs and avoid off target effects. In parallel, we have devised a strategy to readily switch between catalytically active and null Cas9 protein, allowing knocking out and activating target genes in the same cells using distinct gRNAs. By truncating the gRNA from 5â?? end, we have shown that gRNAs with 14nt guide sequences ablate the nuclease activity of Cas9, while leaving its DNA targeting capacity intact. By fusing a Cas9 nuclease protein to a potent activation domain, VPR or application of gRNAs with MS2 binding loops, we can use a same Cas9 protein for transcriptional activation (14nt gRNAs) or gene disruption (20nt gRNAs). By incorporating this capacity within our layered circuits, we have developed and tested several synthetic gene kill switches that can modulate the transcriptional activity of Cas9 protein. Considering the growing clinical application of DNA-based gene therapies and vaccines, the developed CRISPR logic circuits pave the way towards developing safer and more specific gene therapies and allow us to perform more sophisticated biological discoveries.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Stem Cell Research & Therapy.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Stem Cell Research & Therapy
  • SubjectGenetics & Molecular Biology
  • BylineArticles whose byline prints “Samira Kiani”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels